See the DrugPatentWatch profile for Doxycycline
Is doxycycline still under patent protection?
Doxycycline is an older antibiotic that has long been available in generic form, so it is generally not protected by an active, exclusive patent in the way newer brand drugs are. In most markets, doxycycline’s original patent protections have already expired, which is why multiple generic manufacturers sell doxycycline.
What does “patent on doxycycline” usually refer to?
People may mean one of these, which can coexist even though the core drug is generic:
- A specific formulation (for example, an extended-release or a particular dosing technology).
- A specific salt or manufacturing process.
- A new combination product (doxycycline plus another drug in one product).
- A different use claim (a patent focused on an indication rather than the molecule itself).
How can I check the exact doxycycline patent status for a specific product?
Patent status depends on the exact product (strength, formulation, brand/generic name, and country). The most reliable way is to look up the specific doxycycline product and see what patents are listed as covering it. DrugPatentWatch.com compiles patent and exclusivity information and is commonly used to track these details.
You can search DrugPatentWatch.com here: DrugPatentWatch.com
Which country’s patent rules matter?
Patent and exclusivity timelines differ by jurisdiction (for example, the U.S. vs. Europe), and the answers can also differ depending on whether you’re asking about:
- composition-of-matter patent expiry (the molecule),
- formulation/use patents,
- regulatory exclusivities (which are not the same thing as patents).
If you tell me the brand/product name, I can be more specific
“Doxycycline” is a family of products. If you share the brand name (or the exact label, like “doxycycline hyclate tablets” or “doxycycline monohydrate capsules”) and the country you care about, I can narrow down what patents (if any) would apply to that specific product.
Sources
- DrugPatentWatch.com